Stroke refers to an acute cerebrovascular disorder that is manifested by sudden loss or deterioration of brain function, resulting either from ischaemic stroke or intracranial haemorrhage. Here ...

IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

hemi-pontine infarct with trans-axonal degeneration; and diffuse midline glioma with the histone H3K27M mutation. The aim of this pictorial review is to discuss the imaging findings that are relevant ...

Many stroke survivors and families of stroke survivors worry about the safety of flying as a passenger in an airplane after a stroke. Is the concern warranted? It certainly is a common question, so ...

Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced it has exceeded its initial enrollment target for the stroke registrational program evaluating its Portable Neuromodulation Stimulator (PoNS® ...

Stroke Warning Sign Acronyms Drive 911 Calls, F.A.S.T. Leads in Symptom Recall for Public Jan. 30, 2025 — Both F.A.S.T. and BE-FAST acronyms motivated people to call 911 right away for a ...

“Gait and balance deficits are the most frequently occurring disability in stroke patients and represent the largest market opportunity for PoNS Therapy ®,” said Dane Andreeff, Helius Medical ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 million, has surpassed its initial enrollment target for its stroke ...

Helius Medical's President and CEO, Dane Andreeff, expressed excitement about the opportunity to make PoNS available to the over 7 million U.S. patients living with disability from stroke.

The stroke registrational program is designed to evaluate the safety and effectiveness of PoNS or Portable Neuromodulation Stimulator in improving balance and gait deficits in chronic stroke ...